LLNL researcher, business development executive capture technology transfer award from consortium

Submitted by Anonymous (not verified) on
LLNL biologist Nicholas Fischer is analyzing the size of the nanolipoprotein particles (NLPs) by dynamic light scattering in preparation for their use in vaccine applications. Fischer and two former LLNL researchers are key developers of the NLP technology. Photo by Blaise Douros

A Lawrence Livermore National Laboratory (LLNL) researcher and a colleague who helped him and his team commercialize their biomedical technology have garnered a national technology transfer award.

The award, from the Federal Laboratory Consortium (FLC), represents the 42nd technology transfer award that LLNL has won from the FLC since 1985.